Molecular Health, a leader in cloud-based healthcare decision support technology to enable evidence-based treatment decisions and improved outcomes, today announced that the company has opened an office in Berlin, Germany to accelerate the growing European demand for its suite of digital health solutions.

Located on Friedrichstrasse in downtown Berlin close to the government district, the new office reflects Molecular Health´s continued corporate growth and will enable the company to further strengthen its relationships with policy makers and patient advocacy groups in Germany.

Renowned guests at the opening event on November 12, 2015 included Prof. Dr. Christiane Woopen, Chairman of the German Ethics Council and an expert in genome analysis, and Dr. Friedrich von Bohlen, Founder and Chairman of the Board of Molecular Health.